Facing pressure to curb diabetes-treatment costs, the company will cut the list prices for its most commonly prescribed insulin and take other steps to make it easier for patients to afford the drugs.
Original Source Link
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.